LORI LOCKWOOD: Open Payments
NPI 1942686688 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$998 in 49 payments from 21 companies in 2025. Trend: 2023 $946 · 2024 $1,165 · 2025 $998
Food & beverage: $998
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $148 |
| Lilly USA, LLC | 7 | $116 |
| SANOFI-AVENTIS U.S. LLC | 4 | $110 |
| Ascendis Pharma Endocrinology Inc | 5 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| Corcept Therapeutics | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Astellas Pharma US Inc | 2 | $35 |
| Mannkind Corporation | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $33 |
Products named: TZIELD, Yorvipath, Ozempic, JARDIANCE, MOUNJARO, Kerendia, Korlym, Wegovy.
Industry payments across GA — which companies pay providers there.
